Latest Breaking News On - Mark flather - Page 1 : comparemela.com

VistaGen Therapeutics, Inc (NASDAQ:VTGN) Q1 2024 Earnings Call Transcript

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q1 2024 Earnings Call Transcript August 13, 2023 Operator: Greetings, and welcome to the Vistagen Therapeutics Fiscal Year 2024 First Quarter Corporate Update Conference Call. [Operator Instructions] And as a reminder, this conference is being recorded, Thursday, August 10, 2023. I would now like to turn the conference over to Mark […]

United statesAlexander raths shutterstockMark flatherResidential real estate stocks to buyExtremely profitable stocksSocial anxiety disorderShawn singhMark flatherForward looking statementPlacebo effectPublic speaking

VistaGen Therapeutics, Inc (NASDAQ:VTGN) Q3 2023 Earnings Call Transcript

Operator: Greetings. Welcome to VistaGen Therapeutics Third Quarter Fiscal Year 2023 Results Conference Call. At this time all participants are in a listen-only mode.

Shawn singhAndrew tsaiTim lugoTimothy lugoJerrold dotsonJerry dotsonWilliam blairMark flatherExchange commissionVistagen therapeutics incPherin pharmaceuticalsVistagen therapeuticsCall transcript februaryVistagen therapeutics third quarter fiscal yearVice presidentChief executive officer

Vistagen Provides Corporate Update and Reports Fiscal 2023 Third Quarter Financial Results

Pherin acquisition completed; all future royalty payment obligations related to PH94B and PH10 eliminated, three new drug candidates added to Vistagen’s pipelinePH94B Phase 3 program for social anxiety disorder advancing towards important next stepsPH10 Phase 1 study initiated to facilitate plans for Phase 2B develo.

United statesShawn singhNate hitchingsMark flatherCompany phasePherin pharmaceuticalsDrug administrationExchange commissionInternational number tollAcquisition of pherin pharmaceuticals incPherin pharmaceuticals incChief executive officerLiebowitz social anxiety scaleNew drugLabel studyFast track

Vistagen to Report Fiscal Year 2023 Third Quarter Financial Results on February 7, 2023

Vistagen to Report Fiscal Year 2023 Third Quarter Financial Results on February 7, 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNate hitchingsMark flatherWall streetVistagen fiscal yearQuarter results conference callToll freeInternational dial inInvestor relations

Vistagen Announces Closing of Pherin Pharmaceuticals Acquisition

Vistagen Announces Closing of Pherin Pharmaceuticals Acquisition
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shawn singhNate hitchingsMark flatherExchange commissionCompany current report on formPherin pharmaceuticals incWall streetPherin pharmaceuticalsChief executive officerCurrent reportAnnual reportQuarterly reportInvestor relations